Human Medicine:

SYNLAB Laboratory Services Maintains ISO 15189:2012 UKAS Accreditation

7th April 2020 – SYNLAB Laboratory Services, part of Europe’s leading medical diagnostics provider SYNLAB Group, is pleased to announce that the company has successfully maintained its UKAS ISO 15189:2012 accreditation during 2019 following its successful transition from the CPA standards in 2018*.

UKAS is the only national accreditation body which has been recognised by the government to assess against internationally agreed standards – this accreditation demonstrates the competency of a laboratory in testing to ensure reliability of the analysis results and delivers confidence in the service of the testing laboratory.

SYNLAB Laboratory Services is a leading independent laboratory who, through active clinical direction and leadership both locally and in conjunction with SYNLAB UK & Ireland’s Chief Medical Officer Dr David James, offer an ever-expanding repertoire of pathology services including haematology, biochemistry, immunology and virology to a wide variety of wellness / occupational health companies, clinics, hospitals and businesses including insurers across the UK. In addition to laboratory analysis, SYNLAB Laboratory Services offer a range of pathology consumables and home test kits supporting numerous samples types such as blood, swabs, saliva, urine, and faeces, as well as multiple sample collection methods including capillary and finger prick.

Emma Rutter, Head of General Pathology at SYNLAB Laboratory Services commented “We are delighted to have maintained our UKAS 15189 accreditation. This achievement is testament to the ongoing commitment of the SYNLAB Laboratory Services team to upholding the highest standards in quality whilst also achieving industry leading turnaround times and customer service”

The UKAS ISO 15189:2012 accreditation is part of an impressive portfolio that SYNLAB Laboratory Services holds. The laboratory is also an ISO/IEC 17025:2017 accredited testing laboratory No. 2144 and an approved supplier under RSSB’s RISQS (Railway Industry Supplier Qualification Scheme).

SYNLAB Laboratory Services specialise in employee wellness, also offering workplace drug and alcohol testing and collection services throughout the UK, assisting companies across a wide variety of industries in safeguarding their workforces through flexible and innovative testing solutions, minimising the risks associated with drug and alcohol misuse.

Additionally, the company is accredited to the Forensic Regulators Codes of Practice and Conduct and ILAC_G19 which enables the laboratory to conduct testing in relation to section 4 and 5a of the Road Traffic Act (1988) and The Drug Driving (Specified Limits) (England and Wales) Regulations 2014, The Drug Driving (Specified Limits) (England and Wales) (Amendment) Regulations 2015 and The Drug Driving (Specified Limits) (Scotland) Regulations 2019.

SYNLAB Laboratory Services’ full schedule of accreditation can be viewed at www.ukas.com.

For more information on SYNLAB Laboratory Services’ pathology testing services, please click here or contact our Customer Services team on 01873 856688 or [email protected]

*SYNLAB Laboratory Services is a UKAS accredited medical testing laboratory No. 9301.

Latest Human Medicine News
SYNLAB announce partnership with Docly

14 May 2020 New partnership sees comprehensive health tests offered to customers remotely across key UK & Ireland industry sectors UK & Ireland employers and…

Read More (about 'SYNLAB announce partnership with Docly')
Press statement: SYNLAB UK & Ireland confirmed as preferred NHS strategic partner

21 January 2020 SYNLAB UK & Ireland has been confirmed as the preferred strategic partner to transform and deliver NHS pathology services in South East London. SYNLAB…

Read More (about 'Press statement: SYNLAB UK & Ireland confirmed as preferred NHS strategic partner')
Pathology First shortlisted as a finalist for the HSJ Partnership Awards 2020

16 December 2019 SYNLAB UK & Ireland is delighted to announce Pathology First has been shortlisted as a finalist in the category of Best Healthcare…

Read More (about 'Pathology First shortlisted as a finalist for the HSJ Partnership Awards 2020')